Thermo Fisher Net Worth
Thermo Fisher Net Worth Breakdown | TMO |
Thermo Fisher Net Worth Analysis
Thermo Fisher's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Thermo Fisher's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Thermo Fisher's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Thermo Fisher's net worth analysis. One common approach is to calculate Thermo Fisher's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Thermo Fisher's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Thermo Fisher's net worth. This approach calculates the present value of Thermo Fisher's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Thermo Fisher's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Thermo Fisher's net worth. This involves comparing Thermo Fisher's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Thermo Fisher's net worth relative to its peers.
Enterprise Value |
|
To determine if Thermo Fisher is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Thermo Fisher's net worth research are outlined below:
Thermo Fisher generated a negative expected return over the last 90 days | |
Over 91.0% of the company shares are owned by institutional investors | |
On 15th of October 2024 Thermo Fisher paid $ 0.39 per share dividend to its current shareholders | |
Latest headline from thelincolnianonline.com: Thermo Fisher Scientific Inc. Shares Acquired by L S Advisors Inc |
Thermo Fisher Quarterly Good Will |
|
Thermo Fisher uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Thermo Fisher Scientific. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Thermo Fisher's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
31st of January 2024 Upcoming Quarterly Report | View | |
24th of April 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
31st of January 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Know Thermo Fisher's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Thermo Fisher is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Thermo Fisher Scientific backward and forwards among themselves. Thermo Fisher's institutional investor refers to the entity that pools money to purchase Thermo Fisher's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Norges Bank | 2024-06-30 | 5.6 M | Franklin Resources Inc | 2024-06-30 | 4.6 M | Northern Trust Corp | 2024-09-30 | 3.5 M | Massachusetts Financial Services Company | 2024-09-30 | 3.4 M | Royal Bank Of Canada | 2024-06-30 | 3.3 M | Wellington Management Company Llp | 2024-06-30 | 3 M | Legal & General Group Plc | 2024-06-30 | 3 M | Polen Capital | 2024-09-30 | 2.8 M | Bank Of New York Mellon Corp | 2024-06-30 | 2.7 M | Vanguard Group Inc | 2024-09-30 | 33.1 M | Blackrock Inc | 2024-06-30 | 29.5 M |
Follow Thermo Fisher's market capitalization trends
The company currently falls under 'Mega-Cap' category with a total capitalization of 196.32 B.Market Cap |
|
Project Thermo Fisher's profitablity
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.16 | 0.09 | |
Return On Capital Employed | 0.08 | 0.05 | |
Return On Assets | 0.06 | 0.03 | |
Return On Equity | 0.13 | 0.07 |
When accessing Thermo Fisher's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Thermo Fisher's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Thermo Fisher's profitability and make more informed investment decisions.
Evaluate Thermo Fisher's management efficiency
Thermo Fisher Scientific has Return on Asset of 0.0467 % which means that on every $100 spent on assets, it made $0.0467 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1294 %, implying that it generated $0.1294 on every 100 dollars invested. Thermo Fisher's management efficiency ratios could be used to measure how well Thermo Fisher manages its routine affairs as well as how well it operates its assets and liabilities. As of the 23rd of November 2024, Return On Tangible Assets is likely to drop to 0.09. In addition to that, Return On Capital Employed is likely to drop to 0.05. At this time, Thermo Fisher's Other Assets are very stable compared to the past year. As of the 23rd of November 2024, Fixed Asset Turnover is likely to grow to 4.79, while Net Tangible Assets are likely to drop (13.7 B).Last Reported | Projected for Next Year | ||
Book Value Per Share | 121.35 | 127.42 | |
Tangible Book Value Per Share | (35.88) | (34.08) | |
Enterprise Value Over EBITDA | 21.46 | 12.26 | |
Price Book Value Ratio | 4.38 | 4.60 | |
Enterprise Value Multiple | 21.46 | 12.26 | |
Price Fair Value | 4.38 | 4.60 | |
Enterprise Value | 217.7 B | 228.5 B |
Thermo Fisher Scientific has shown resilience through effective management strategies. Our analysis examines how these strategies influence financial outcomes and investor returns which helps in understanding the stock's long-term potential.
Enterprise Value Revenue 5.3101 | Revenue 42.4 B | Quarterly Revenue Growth 0.002 | Revenue Per Share 110.627 | Return On Equity 0.1294 |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Thermo Fisher insiders, such as employees or executives, is commonly permitted as long as it does not rely on Thermo Fisher's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Thermo Fisher insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Scott Sperling over a month ago Acquisition by Scott Sperling of tradable shares of Thermo Fisher subject to Rule 16b-3 | ||
Marc Casper over three months ago Disposition of 610 shares by Marc Casper of Thermo Fisher at 578.3 subject to Rule 16b-3 | ||
Joseph Holmes over six months ago Disposition of tradable shares by Joseph Holmes of Thermo Fisher at 593.03 subject to Rule 16b-3 | ||
Peter Wilver over a year ago Acquisition by Peter Wilver of 27000 shares of Thermo Fisher subject to Rule 16b-3 |
Thermo Fisher Corporate Filings
F4 | 12th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
10Q | 1st of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
8K | 23rd of October 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
12th of September 2024 Other Reports | ViewVerify |
Thermo Fisher Earnings per Share Projection vs Actual
Thermo Fisher Corporate Directors
Tyler Jacks | Independent Director | Profile | |
James Mullen | Independent Director | Profile | |
Dion Weisler | Independent Director | Profile | |
Debora Spar | Independent Director | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Thermo Fisher Scientific. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Thermo Fisher. If investors know Thermo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Thermo Fisher listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.04) | Dividend Share 1.52 | Earnings Share 15.96 | Revenue Per Share 110.627 | Quarterly Revenue Growth 0.002 |
The market value of Thermo Fisher Scientific is measured differently than its book value, which is the value of Thermo that is recorded on the company's balance sheet. Investors also form their own opinion of Thermo Fisher's value that differs from its market value or its book value, called intrinsic value, which is Thermo Fisher's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Thermo Fisher's market value can be influenced by many factors that don't directly affect Thermo Fisher's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Thermo Fisher's value and its price as these two are different measures arrived at by different means. Investors typically determine if Thermo Fisher is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Thermo Fisher's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.